The Wolverine Blend is a dual-peptide research compound containing BPC-157 at 5mg and TB-500 (Thymosin Beta-4 synthetic analog) at 5mg in a single lyophilized vial. Both peptides have been independently studied for their roles in tissue repair, and this combination is of interest in research examining whether their mechanisms of action produce complementary or synergistic effects in preclinical models.

BPC-157, a 15-amino acid pentadecapeptide, has been studied for its effects on angiogenesis, nitric oxide modulation, and repair processes in tendons, ligaments, and gastrointestinal tissue. TB-500, a synthetic analog of Thymosin Beta-4, has been investigated for its role in actin regulation, cellular migration, inflammation modulation, and vascular remodeling. Together, the two compounds address overlapping yet distinct aspects of the tissue repair process, making the combination a subject of preclinical research interest.

Researchers studying musculoskeletal repair, wound healing kinetics, and regenerative peptide combinations commonly reference BPC-157 and TB-500 as a co-administration protocol. The Wolverine Blend offers a pre-combined lyophilized format for simplified research use, particularly in studies where consistent compound ratios are required.

Disclaimer: This product is intended for in vitro research and laboratory use only. It is not intended for human or veterinary use, consumption, or injection. Not approved by the FDA. Not intended to diagnose, treat, cure, or prevent any disease or medical condition. For use by qualified researchers only.